The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letters to the EditorFull Access

Omega-3s Do Offer Hope

Published Online:https://doi.org/10.1176/pn.42.12.0023b

The headline on the news article on the trial of omega-3 fatty acids in the April 6 issue was strikingly misleading. While the open-label trial found“ some improvement in manic symptoms in children with bipolar illness,” the headline proclaimed, “Latest Hope for Omega-3 Fatty Acids Shot Down for Child Bipolar Illness.”

I'd say the quoted finding of a 30 percent reduction in the Young Mania Rating Scale scores in half the subjects is quite hopeful. The concern about“ nonspecific study effects” is a concern in all research and shouldn't lead us to reject such a safe, sensible approach to a very difficult clinical challenge.

Farmville, N.C.